Inhibin-A antagonizes TGFβ2 signaling by down-regulating cell surface expression of the TGFβcoreceptor betaglycan

Molecular Endocrinology

Volumn 24, Issue 3, 2010, Pages 608-620

  Looyenga, Brendan D ^a   Wiater, Ezra ^b   Vale, Wylie ^b   Hammer, Gary D ^c  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; INHIBIN A; LUTEINIZING HORMONE; RECOMBINANT PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA2; INHIBIN; PROTEOGLYCAN;

ADRENAL CORTEX; ADRENAL CORTEX CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; HORMONE ACTION; KNOCKOUT MOUSE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ADRENAL CORTEX; ANIMALS; CELLS, CULTURED; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; INHIBINS; MICE; MICE, MUTANT STRAINS; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 77249134230     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0374     Document Type: Article

References (36)

1. Chang H, Brown CW, Matzuk MM 2002 Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr Rev 23:787-823
2. Matzuk MM, Lamb DJ 2002 Genetic dissection of mammalian fertility pathways. Nat Cell Biol 4(Suppl):s41-s49
3. Cook RW, Thompson TB, Jardetzky TS, Woodruff TK 2004 Molecular biology of inhibin action. Semin Reprod Med 22:269-276
4. Ethier JF, Findlay JK 2001 Roles of activin and its signal transduction mechanisms in reproductive tissues. Reproduction 121:667-675
5. Massagué J, Seoane J, Wotton D 2005 Smad transcription factors. Genes Dev 19:2783-2810
6. Bernard DJ, Chapman SC, Woodruff TK 2001 Mechanisms of inhibin signal transduction. Recent Prog Horm Res 56:417-450
7. Lebrun JJ, Vale WW 1997 Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Mol Cell Biol 17:1682-1691
8. Gray PC, Bilezikjian LM, Vale W 2002 Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan. Mol Cell Endocrinol 188:254-260
9. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massagué J 1990 Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem 265:20533-20538
10. Ethier JF, Farnworth PG, Findlay JK, Ooi GT 2002 Transforming growth factor-β modulates inhibin A bioactivity in the LβT2 gonadotrope cell line by competing for binding to betaglycan. Mol Endocrinol 16:2754-2763
11. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A 1994 Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 91:8817-8821
12. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A 1992 α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-319
13. El-Hefnawy T, Zeleznik AJ 2001 Synergism between FSH and activin in the regulation of proliferating cell nuclear antigen (PCNA) and cyclin D2 expression in rat granulosa cells. Endocrinology 142: 4357-4362
14. Miró F, Hillier SG 1996 Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin. Endocrinology 137:464-468
15. Looyenga BD, Hammer GD 2006 Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex. Mol Endocrinol 20:2848-2863
16. Beuschlein F, Looyenga BD, Bleasdale SE, Mutch C, Bavers DL, Parlow AF, Nilson JH, Hammer GD 2003 Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol Cell Biol 23: 3951-3964
17. Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byrne MC, Matzuk MM 1999 Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Mol Endocrinol 13:851-865
18. Kumar TR, Wang Y, Matzuk MM 1996 Gonadotropins are essential modifier factors for gonadal tumor development in inhibindeficient mice. Endocrinology 137:4210-4216
19. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, Keri RA, Huhtaniemi IT 2000 Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest 105:633-641
20. Looyenga BD, Hammer GD 2007 Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery. Mol Endocrinol 21:2440-2457
21. Kingsley-Kallesen ML, Kelly D, Rizzino A 1999 Transcriptional regulation of the transforming growth factor-β 2 promoter by cAMP-responsive element-binding protein (CREB) and activating transcription factor-1 (ATF-1) is modulated by protein kinases and the coactivators p300 and CREB-binding protein. J Biol Chem 274: 34020-34028
22. Costa ET, Forti FL, Rocha KM, Moraes MS, Armelin HA 2004 Molecular mechanisms of cell cycle control in the mouse Y1 adrenal cell line. Endocr Res 30:503-509
23. Cherradi N, Chambaz EM, Defaye G 1995 Type β1 transforming growth factor is an inhibitor of 3β-hydroxysteroid dehydrogenase isomerase in mouse adrenal tumor cell line Y1. Endocr Res 21:61-66
24. Subramaniam M, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC 1995 TGF-β regulation of nuclear proto-oncogenes and TGF-β gene expression in normal human osteoblast-like cells. J Cell Biochem 57:52-61
25. Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP, Wang XF, Lefkowitz RJ, Blobe GC 2003 β-Arrestin 2 mediates endocytosis of type III TGF-β receptor and down-regulation of its signaling. Science 301:1394-1397
26. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL 2003 Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 5:410-421
27. Le Roy C, Wrana JL 2005 Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6:112-126
28. Ivanov AI 2008 Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol 440:15-33
29. Wiater E, Harrison CA, Lewis KA, Gray PC, Vale WW 2006 Identification of distinct inhibin and transforming growth factor β-binding sites on betaglycan: functional separation of betaglycan co-receptor actions. J Biol Chem 281:17011-17022
30. Sankar S, Mahooti-Brooks N, Centrella M, McCarthy TL, Madri JA 1995 Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor β 2. J Biol Chem 270:13567-13572
31. Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler S, Grail D, Small C, Weinberg RA, Sizeland AM, Zhu HJ 2003 Heart and liver defects and reduced transforming growth factor β2 sensitivity in transforming growth factor β type III receptor-deficient embryos. Mol Cell Biol 23:4371-4385
32. Tang H, Low B, Rutherford SA, Hao Q 2005 Thrombin induces endocytosis of endoglin and type-II TGF-β receptor and downregulation of TGF-β signaling in endothelial cells. Blood 105: 1977-1985
33. de Fraipont F, El Atifi M, Cherradi N, Le Moigne G, Defaye G, Houlgatte R, Bertherat J, Bertagna X, Plouin PF, Baudin E, Berger F, Gicquel C, Chabre O, Feige JJ 2005 Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab 90:1819-1829
34. Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM, Hanash SM 2003 Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 162:521-531
35. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH 1995 Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 92:1322-1326
36. Yu JY, DeRuiter SL, Turner DL 2002 RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 99:6047-6052